Prescient Therapeutics
Prescient Therapeutics

Prescient Therapeutics Information

Contact top employees from Prescient Therapeutics

Summary

Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies. Prescient’s technologies emanat...Show more

Organization Website

ptxtherapeutics.com

Industries

Headquarters Location

Level 11, 385 Bourke Street, Melbourne, Victoria, 3205 AU

Employees Size

10-50 employees

Founded

2014

Employees Turnover 4 quarter 2025

Length of Employment
arrow
Employee tenure at Prescient Therapeutics shows a diverse range of experience levels:
27% have been with the company for less than 1 year18% for 1–2 years9% for 3–4 years9% for 5–7 years27% for 8–10 years9% have over 11 years of service at Prescient Therapeutics
Contact top employees from Prescient Therapeutics
Terrence Chew
Chief Medical Officer
View
Said Sebti
Chief Scientific Officer
View
James McDonnell
Chief Executive Officer
View
Luis Malaver
Director of Research Development
View
Mariam Mansour
Senior Director – Clinical Development and Translational Sciences
View
Upaly Bahadure
Director Clinical Affairs and Operations
View
Rebecca Tunstall
Chief Operating Officer
View
Gavin Shepherd
Non Executive Director
View

FAQ

Prescient Therapeutics operates in the Biotech industries. More details can be found on the official website: ptxtherapeutics.com.
The headquarters of Prescient Therapeutics are located in Melbourne, Australia.
Prescient Therapeutics currently employs 10-50 people.

Data Privacy

GDPR Icon

GDPR COMPLIANT

SignalHire complies with the General Data Protection Regulation (GDPR). SignalHire follows GDPR requirements, including but not limited to rights of data subjects to access, correct, or delete their personal information and supports the right to be forgotten.

CCPA Icon

CCPA COMPLIANT

SignalHire is CCPA-compliant and provides California residents the right to know, access, opt out, and request deletion of their personal data.

BACK TO TOP